Weekly Assessment of the COVID-19 Pandemic and Risk of Importation — China, March 25, 2020
Mingfan Pang(Chinese Center For Disease Control and Prevention), Xiao‐Ping Dong(Chinese Academy of Sciences), Zuoru Liang(Chinese Center For Disease Control and Prevention), Zhida Cheng(Cloud Computing Center), Ke Lyu(Chinese Center For Disease Control and Prevention), Yufei Wang(First Affiliated Hospital of Zhengzhou University), Jun Zhang(Tencent (China)), Yanping Zhang(Cell and Gene Therapy Catapult), Xinhua Li, Zhongjie Li(Capital Medical University), Xinping Yang(Chinese Center For Disease Control and Prevention), Wenxiao Tu, Guo Li(Cloud Computing Center), Zengtao Jiao(Cloud Computing Center), Xiaopeng Qi(Chinese Center For Disease Control and Prevention), Nan Huang(Sun Yat-sen University)
Cited by 6
Related Papers
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698
Particle Swarm Optimization With an Aging Leader and Challengers
|IEEE Transactions on Evolutionary Computation|2012|634
Signaling to p53: Ribosomal Proteins Find Their Way
|Cancer Cell|2009|569
Etiological and epidemiological features of acute respiratory infections in China
|Nature Communications|2021|530